VistaGen Therapeutics
VTGN
VTGN
22 hedge funds and large institutions have $3.23M invested in VistaGen Therapeutics in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 0.32% → 0.35% (+0.03%)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$171K | |
| 2 | +$146K | |
| 3 | +$99K | |
| 4 |
RC
RBF Capital
San Francisco,
California
|
+$35K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$31.6K |
Top Sellers
| 1 | -$133K | |
| 2 | -$28.7K | |
| 3 | -$14K | |
| 4 |
BCWM
Bartlett & Co Wealth Management
Cincinnati,
Ohio
|
-$13.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$12K |